Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02132624 |
|---|---|
| Brief Title: | CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial. |
| First Submitted : | May 5, 2014 |
| First Submitted that Met QC Criteria : | May 5, 2014 |
| First Posted : | May 7, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | October 27, 2017 |
| Last Update Posted : | October 30, 2017 |